Patent details

980031 Product Name: Rivastigmine, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, in het bijzonder Rivastigmine waterstoftar- traat.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
980031
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0193926
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
980031
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

1

Marketing Authorization Number:
EU/1/98/066/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

2

Marketing Authorization Number:
EU/1/98/066/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

3

Marketing Authorization Number:
EU/1/98/066/003
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

4

Marketing Authorization Number:
EU/1/98/066/004
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

5

Marketing Authorization Number:
EU/1/98/066/005
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

6

Marketing Authorization Number:
EU/1/98/066/006
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

7

Marketing Authorization Number:
EU/1/98/066/007
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

8

Marketing Authorization Number:
EU/1/98/066/008
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

9

Marketing Authorization Number:
EU/1/98/066/010
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

10

Marketing Authorization Number:
EU/1/98/066/009
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

11

Marketing Authorization Number:
EU/1/98/066/011
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

12

Marketing Authorization Number:
EU/1/98/066/012
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

13

Marketing Authorization Number:
EU/1/98/066/001
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

14

Marketing Authorization Number:
EU/1/98/066/002
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

15

Marketing Authorization Number:
EU/1/98/066/003
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

16

Marketing Authorization Number:
EU/1/98/066/004
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

17

Marketing Authorization Number:
EU/1/98/066/005
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

18

Marketing Authorization Number:
EU/1/98/066/006
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

19

Marketing Authorization Number:
EU/1/98/066/007
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

20

Marketing Authorization Number:
EU/1/98/066/008
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

21

Marketing Authorization Number:
EU/1/98/066/009
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

22

Marketing Authorization Number:
EU/1/98/066/010
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

23

Marketing Authorization Number:
EU/1/98/066/011
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

24

Marketing Authorization Number:
EU/1/98/066/012
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/05/1998
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
05/11/1998
First Marketing Authorization date:
12/05/1998
Grant date:
03/02/1999
Activation date:
04/03/2006
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
05/11/1998
SPC/SPC Extension Expiration Date:
03/03/2011
Lapsed By Expiration Date:
04/03/2011
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
05/11/1998
 
 

 

Name:
Proterra AG
Address:
Poststrasse 8, CH-6300 ZUG, Switzerland (CH)

Agent

Name:
ir. F.A. Geurts c.s.
From:
05/11/1998
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Licensee

Name:
Novartis AG
From:
28/10/2009
Address:
Lichtstrasse 35, CH-4056 Basel, Switzerland (CH)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
2011/11
Publication date:
16/03/2011
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
1999/09
Publication date:
01/09/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
1999/09
Publication date:
01/09/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
1999/03
Publication date:
01/03/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
1999/03
Publication date:
01/03/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

6

Bulletin Heading:
SPC
Journal edition number:
1999/01
Publication date:
04/01/1999
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
LRFC-22A
Date Registered:
28/10/2009
License Effective Date:
28/10/2009
License Expiration Date:
Scope of License:
Exclusive
Journal Edition Number:
Text:
Deed Status:
Country Code:
Switzerland (CH)
Updated License Number:
Terminated License Number:

Added Licensee(s)

Name:
Novartis AG
Address:
Lichtstrasse 35, CH-4056 Basel, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
54387-A054387-1
Date Registered:
28/10/2009
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Freshfields Bruckhaus Deringer
Journal Edition Number:
Text:
Licentieovereenkomst ingediend door Freshfields Bruckhaus Deringer te Amsterdam d.d. 23 oktober 2009 op verzoek van Licentiegever Novartis AG. aan de Licentienemer Proterra AG. Zie verder de akte.
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
30/03/2010
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Octrooibureau Vriesendorp&Gaade BV
Filing date Document type Document Description Number of pages File Type
17/03/2008 General 2 PDF /1/3/0/0/8/0400980031/docs/980031_6_spc-documents20080317.pdf
17/03/2008 General 8 PDF /1/3/0/0/8/0400980031/docs/980031_8_spc-documents20080317.pdf
22/12/1998 Outgoing Correspondence Outgoing Letter 2 PDF /1/3/0/0/8/0400980031/docs/980031_3_outgoingcorrespondence19981222.pdf
22/12/1998 Outgoing Correspondence Outgoing Letter 1 PDF /1/3/0/0/8/0400980031/docs/980031_9_outgoingcorrespondence19981222.pdf
20/11/1998 Outgoing Correspondence Outgoing Letter 2 PDF /1/3/0/0/8/0400980031/docs/980031_10_outgoingcorrespondence19981120.pdf
05/11/1998 General 4 PDF /1/3/0/0/8/0400980031/docs/980031_0_spc-documents19981105.pdf
05/11/1998 General 7 PDF /1/3/0/0/8/0400980031/docs/980031_1_spc-documents19981105.pdf
05/11/1998 Application Form First filed application form 2 PDF /1/3/0/0/8/0400980031/docs/980031_2_applicationform19981105.pdf
05/11/1998 General 1 PDF /1/3/0/0/8/0400980031/docs/980031_4_spc-documents19981105.pdf
05/11/1998 General 2 PDF /1/3/0/0/8/0400980031/docs/980031_5_spc-documents19981105.pdf
05/11/1998 General 2 PDF /1/3/0/0/8/0400980031/docs/980031_7_spc-documents19981105.pdf